Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase
暂无分享,去创建一个
Sarah J. Thackray | G. Montelione | T. Acton | S. Vorobiev | R. Xiao | F. Forouhar | J. Seetharaman | S. Chapman | J. L. Anderson | M. Abashidze | C. Bruckmann | Li Zhao | C. Mowat | A. Hussain | Lichung Ma | T. Tucker | L. Tong
[1] H. Sugimoto,et al. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[2] Andrew Mellor,et al. Indoleamine 2,3 dioxygenase and regulation of T cell immunity. , 2005, Biochemical and biophysical research communications.
[3] O. Takikawa. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism. , 2005, Biochemical and biophysical research communications.
[4] Michael Platten,et al. Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite , 2005, Science.
[5] A. Munro,et al. Redox and spectroscopic properties of human indoleamine 2,3-dioxygenase and a His303Ala variant: implications for catalysis. , 2005, Biochemistry.
[6] G. Prendergast,et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy , 2005, Nature Medicine.
[7] Jonathan P. Clark,et al. 4-Cyanopyridine, a Versatile Spectroscopic Probe for Cytochrome P450 BM3* , 2004, Journal of Biological Chemistry.
[8] D. Munn,et al. Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.
[9] D. Rousseau,et al. Crystal Structure of the Dioxygen-bound Heme Oxygenase from Corynebacterium diphtheriae , 2004, Journal of Biological Chemistry.
[10] R. Schwarcz. The kynurenine pathway of tryptophan degradation as a drug target. , 2004, Current opinion in pharmacology.
[11] C. Uyttenhove,et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase , 2003, Nature Medicine.
[12] R. Truscott,et al. Asp274 and His346 Are Essential for Heme Binding and Catalytic Function of Human Indoleamine 2,3-Dioxygenase* , 2003, Journal of Biological Chemistry.
[13] U. Grohmann,et al. Tolerance, DCs and tryptophan: much ado about IDO. , 2003, Trends in immunology.
[14] Andrew C. Terentis,et al. The Heme Environment of Recombinant Human Indoleamine 2,3-Dioxygenase , 2002, The Journal of Biological Chemistry.
[15] G Jogl,et al. COMO: a program for combined molecular replacement. , 2001, Acta crystallographica. Section D, Biological crystallography.
[16] M. Walker,et al. Expression and purification of recombinant human indoleamine 2, 3-dioxygenase. , 2000, Protein expression and purification.
[17] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[18] Russ Miller,et al. The design and implementation of SnB version 2.0 , 1999 .
[19] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.
[20] D. Munn,et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.
[21] J. Dawson,et al. Heme-Containing Oxygenases. , 1996, Chemical reviews.
[22] J. Navaza,et al. AMoRe: an automated package for molecular replacement , 1994 .
[23] C. Sander,et al. Protein structure comparison by alignment of distance matrices. , 1993, Journal of molecular biology.
[24] M. Sono,et al. 1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. , 1991, Archives of biochemistry and biophysics.
[25] W. Hendrickson. Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. , 1991, Science.
[26] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[27] M. Sono. Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 2. Evidence for the existence of another binding site in the enzyme for indole derivative effectors. , 1989, Biochemistry.
[28] T. Tatusova,et al. Reannotation of Shewanella oneidensis genome. , 2003, Omics : a journal of integrative biology.
[29] Thomas C Terwilliger,et al. SOLVE and RESOLVE: automated structure solution and density modification. , 2003, Methods in enzymology.
[30] Z. Otwinowski,et al. [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.
[31] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[32] O. Hayaishi,et al. [26] Indoleamine 2,3-dioxygenase , 1987 .
[33] Y. Ishimura,et al. Regulatory control and catalytic mechanisms of L-tryptophan 2,3-dioxygenase (pyrrolase). , 1980, Advances in enzyme regulation.
[34] Y. Ishimura. [52] l-tryptophan 2,3-dioxygenase (tryptophan pyrrolase) (pseudomonas fluorescens) , 1970 .